Mabtas 500 – Rituximab Injection for Cancer & Autoimmune Disorders

Mabtas 500 contains Rituximab (500 mg), a monoclonal antibody used in the treatment of non-Hodgkin’s lymphoma (NHL), chronic lymphocytic leukemia (CLL), and autoimmune diseases like rheumatoid arthritis. It works by targeting and destroying specific immune cells responsible for cancer and inflammatory conditions. Administered via intravenous infusion under medical supervision.